NEOconcepts, a distributor of aesthetic medical devices for dermatologists, plastic surgeons, and other medical aesthetic providers, has inked an exclusive deal with Italian company Triworks to introduce AgeJET nitrogen plasma technology to the U.S. market. AgeJET is a non-ablative, anti-aging skin regeneration therapy that requires just one treatment to see benefits without surgery or downtime.
“The U.S. market has never had adequate access to this unique, high-end nitrogen plasma technology. The recent nationwide availability of AgeJET targets an unmet need among physicians in the U.S.,” says Matthew Brulport, president and CEO of NEOconcepts.
Nitrogen plasma works by exciting nitrogen atoms with ultra-high frequency energy to produce a thermal plasma burst that penetrates into the dermis. This technology treats 100% of the dermal architecture compared to only fractional areas of skin with lasers, making it suitable to treat areas around the eyes.
“For the first time, we are able to address the sensitive upper and lower eyelid tissue to the lash line. AgeJET Eye is the most effective energy-based treatment to address the appearance of aging eyes in a single 10-minute treatment with little downtime,” says Mikel Lo, MD, board-certified oculofacial plastic surgeon.
Triworks recognizes the opportunity to introduce this technology to the U.S. market, company officials say. “We are excited about our partnership with NEOconcepts, and confident that AgeJET’s proven clinical efficacy and safety will be well received by physicians globally,” adds TriWorks President Elio Berccici.
Matthew Brulport, president of NEOconcepts, also spoke out about the deal, commenting: “Our exclusive partnership with Triworks supports our company’s heritage of bringing novel, innovative technologies to the aesthetic market. We are committed to delivering an ever-improving patient experience while meeting our customers’ need for clinical efficacy and profitability. Triwork’s expertise in manufacturing high-quality devices makes all this possible.”